Archangels - Making The Future

Press Releases

  • ARCHANGELS MAKE THE PACE IN 2013

    27 Feb 2014

    Archangels led the angel field in Scotland again in 2013 with investment of £10.2million, a similar amount to most recent years (2012 £9.5million). £5.2million (2012 £5.73m) of this came from Archangel members which constitutes almost half the amount invested in 2013 by all the angel groups in Scotland taken together. The remaining £5m came from SIB (£2.5m), VCs (£2m) and other angels.

  • In their 20th anniversary year of 2012 Archangels backed

    27 Feb 2013

    Archangels once more, was Scotland’s largest business angel funder in 2012, leading £9.5m of investment (2011 - £8.75m), and is celebrating its 20th anniversary. Mike Rutterford and Barry Sealey invested together first, in Optos, in October 1992.

  • Archangels backed Scottish early stage firms with

    27 Feb 2012

    Archangels retained its position as Scotland’s biggest provider of business angel funding in 2011, leading £8.75m of investment (2010 - £8.3m).

  • Annual Review 2009

    24 Feb 2010

    Archangels, the Edinburgh based business angel group, today released its annual review of activities, commented on the health of the key angel funding market in Scotland and announced its predictions for this coming year.

View archived articles |   

Latest News

Cable gets to grips with Great British design

25 Jun 2014
Business Secretary, Vince Cable, saw bionic limbs, an airship and a model of a hypersonic aircraft when he launched the ‘Pioneering Great British Products' report at Liverpool's Life Sciences University Technical College.

MGB Biopharma Expands Scientific Advisory Board (SAB) with Medical Microbiologist Dr Stephanie Dancer

23 Jun 2014
MGB Biopharma, a biopharmaceutical company developing truly novel anti-infectives, announces today that Dr Stephanie Dancer, an internationally renowned medical microbiologist, has joined its scientific advisory board (SAB). She will help oversee the development of MGB Biopharma’s lead antibiotic candidate, MGB-BP-3. An oral formulation of MGB-BP-3 is ready to enter Phase I development for Clostridium difficile, and an iv presentation is in late preclinical development for Gram-positive hospital acquired infections.

Touch Bionics founder receives Queen’s Honour

16 Jun 2014
David Gow named Commander of the Order of the British Empire Touch Bionics, a provider of world-leading prosthetic technologies, is proud to announce that the company's founder, David Gow, was named Commander of the Order of the British Empire (CBE) in this year's Queen's Birthday Honours list.

Touch Bionics introduces new control method for bionic hand

14 May 2014
Livingston, Scotland – May 14, 2014 – Touch Bionics, a provider of world-leading prosthetic technologies, has announced the introduction of the latest enhancements to the i-limb™ ultra revolution at the OTWorld 2014 International Congress taking place in Leipzig, Germany.

Technology Strategy Board Biomedical Catalyst Award to Drive Development of Novel System to Assess and Manage Tooth Decay (Dental Caries)

09 May 2014
Calcivis, a medical devices company focused on revolutionising the management of tooth decay, today announces that it has received a prestigious Biomedical Catalyst award co-funding a £0.5m development programme and raised a further £0.8m in equity funding from existing investors Archangel Informal Investment and the Scottish Investment Bank, the investment arm of Scottish Enterprise.